Clinical Trials Search Results Display: Title Description with: Locations Eligibility Full Trial Description Custom ? Hide Search Criteria Show Search Criteria Drug: nicotine patchFind trials that include: Any drugs shown Results 1-13 of 13 for your search: Start Over Select All on Page Sort by: Phase of Trial Title Type of Trial Status of Trial Age Range Trial ID Show 10 25 50 100 200 Results per Page 1. Behavioral Counseling and Nicotine Replacement Therapy or Varenicline in Helping Smokers Quit Status: ActivePhase: Phase IVType: Behavioral study, Biomarker/Laboratory analysis, PreventionAge: 18 to 65Trial IDs: 2014-0207, NCI-2014-01485, NCT02162849 2. Varenicline and Nicotine Replacement Therapy for Initial Smoking Cessation and Treatment in Smokers Status: ActivePhase: Phase IVType: Behavioral study, PreventionAge: 18 to 65Trial IDs: 2014-0213, NCI-2015-00610, NCT02271919 3. Genetically Informed Smoking Cessation Interventions in Helping People Quit Smoking Status: ActivePhase: Phase IVType: Biomarker/Laboratory analysis, TreatmentAge: 18 and overTrial IDs: 201305128, NCI-2015-00792, NCT02351167 4. Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers Status: ActivePhase: Phase IVType: Biomarker/Laboratory analysis, PreventionAge: 18 and overTrial IDs: STUDY00001602, NCI-2015-01331, AD-1310-08709, NCI-2015-00937, NCT02244918 5. Proactive Counseling and Nicotine Replacement Therapy in Changing the Default for Tobacco Treatment in Smokers Status: Enrolling by invitationPhase: Phase IVType: Prevention, Supportive careAge: 18 and overTrial IDs: STUDY00001774, NCI-2016-01534, NCT02721082 6. Nicotine Patch in Treating Chemotherapy-Induced Cognitive Impairment in Patients with Stage I-IIIA Breast, Colon, or Ovarian Cancer or Lymphoma Status: ActivePhase: Phase IIType: Supportive careAge: 35 to 80Trial IDs: VICC BRE 1692, NCI-2016-01195, NCT02312934 7. Motivation and Problem-Solving Approach in Promoting Smoking Cessation in Cervical Cancer Survivors Status: ActivePhase: No phase specifiedType: Behavioral studyAge: 18 and overTrial IDs: 2014-0204, NCI-2015-00067, NCT02157610 8. Smartphone-Delivered Attentional Bias Modification Training in Helping Patients Quit Smoking Status: ActivePhase: No phase specifiedType: Behavioral studyAge: 18 to 65Trial IDs: 2013-0999, NCI-2015-00609, NCT02224391 9. Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients with Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy with or without Chemotherapy Status: ActivePhase: No phase specifiedType: Biomarker/Laboratory analysis, PreventionAge: 18 and overTrial IDs: CCCWFU 98415, NCI-2015-01714, NCT02582008 10. Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation Status: ActivePhase: No phase specifiedType: PreventionAge: 18 to 75Trial IDs: 2015-0879, NCI-2016-00674, NCT02697227 11. Varenicline or Varenicline-Based Adaptive Pharmacotherapy with High or Low Intensity Behavioral Programs in Helping Smokers Quit Smoking Status: ActivePhase: No phase specifiedType: TreatmentAge: 18 and overTrial IDs: Pro00072077, NCI-2017-00062, NCT02501265 12. Culturally-Tailored Internet-Based Smoking Cessation Program in Quitting Smoking in Tribal College Students Status: ActivePhase: No phase specifiedType: PreventionAge: 18 and overTrial IDs: 13613, NCI-2017-00812, NCT02050308 13. Adaptive Smoking Cessation Interventions in Smokers Undergoing Lung Cancer Screening Status: ActivePhase: No phase specifiedType: Prevention, Supportive careAge: 55 to 79Trial IDs: 2015NTLS048, NCI-2017-01074, NCT02597491 Select All on Page Start Over
